Back
Speaker illustration

Professor Pia Kamstrup

Copenhagen University Hospital, Copenhagen (Denmark)

Presentations Articles

Guideline recommendations for Lp(a)

Event: ESC Congress 2025

Topic: Risk Factors and Prevention

Session: Lp(a) in cardiovascular disease: current insights and future therapies

Access
Like
Thumbnail

Cardiovascular risk associated with Lp(a)

Event: ESC Congress 2025

Topic: Risk Factors and Prevention

Session: Lp(a) in cardiovascular disease: current insights and future therapies

Access
Like
Thumbnail

Discussion.

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Lp(a): from causality to therapy

Access
Like
Thumbnail

Targeting Lp(a) in CV risk reduction: where are we now?

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Lp(a): from causality to therapy

Access
Like
Thumbnail

Guidance on Lp(a) measurement: why, how, when?

Event: ESC Congress 2022

Topic: Cardiovascular Risk Assessment

Session: Uncovering the hidden risk: why lipoprotein(a) testing is crucial

Access
Like
Thumbnail

Lp(a) as target in cardiovascular prevention: Why worry and how to assess?

Event: ESC Congress 2020

Topic: Lipids

Session: Lp(a), a new lipid frontier in CV risk management & target for therapy

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources